Cancer Hospital of Chinese Academy of Medical Science

Beijing 100021

0 studies enrolling now · 4 studies all time

What they study most

Breast Neoplasms, Liposarcoma, Dedifferentiated, Lung Cancer, Non-squamous, Non-small Cell, Triple Negative Breast Cancer

Studies at this site

• Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment — Running, not enrolling
• Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma — Completed
• LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment — Completed
• Phase 2 Study - Aurora + Angiogenic Kinase Inhibitor ENMD-2076 in Previously Treated Locally Advanced + Metastatic TNBC — Completed